A Novel Mouse Model for Cerebral Inflammatory Demyelination in X‐Linked Adrenoleukodystrophy: Insights into Pathogenesis and Potential Therapeutic Targets

Our results suggest loss of Abcd1 function in mice predisposes to more severe blood-brain barrier disruption, cerebral inflammation driven by the infiltration of peripheral immune cells, demyelination, and axonal damage, replicating human cALD features. This novel mouse model could shed light on cALD mechanisms and accelerate cALD therapy development. ANN NEUROL 2025;97:296-312.

Authors

Institutions

Publication Details

Journal
Annals of Neurology
Published
2024-10-28
DOI
https://doi.org/10.1002/ana.27117
Citations
3
Primary Topic
Peroxisome Proliferator-Activated Receptors
Type
article
Field-Weighted Citation Impact
0.70

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Novel Mouse Model for Cerebral Inflammatory Demyelination in X‐Linked Adrenoleukodystrophy: Insights into Pathogenesis and Potential Therapeutic Targets

Katerina Akassoglou, William H. Robinson, Shahrzad Talebian, Avni Awani et al.
3 citations
Annals of Neurology
Peroxisome Proliferator-Activated Receptors
0.70
article

A Novel Mouse Model for Cerebral Inflammatory Demyelination in X‐Linked Adrenoleukodystrophy: Insights into Pathogenesis and Potential Therapeutic Targets

Katerina Akassoglou, William H. Robinson, Shahrzad Talebian, Avni Awani, Esha Kaushal, Patricia L. Musolino, Troy C. Lund, May Han, Ezra Yoseph, Laura Pisani, Paul J. Orchard, Hannes Vogel, Orr Sharpe, Ezzat Hashemi, Joshua L. Bonkowsky, Keith Van Haren, Lawrence Steinman, Isha N. Srivastava, Kristian P. Doyle, Alejandro Aguirre, Romain Cayrol, Jae Kyu Ryu, Max Lenail, Pauline Chu
article en
3 citations

Abstract

Our results suggest loss of Abcd1 function in mice predisposes to more severe blood-brain barrier disruption, cerebral inflammation driven by the infiltration of peripheral immune cells, demyelination, and axonal damage, replicating human cALD features. This novel mouse model could shed light on cALD mechanisms and accelerate cALD therapy development. ANN NEUROL 2025;97:296-312.

Annals of NeurologyVol. 97(2)
University of Minnesota (US), Gladstone Institutes (US), Primary Children's Hospital (US), University of Arizona (US), University of California, San Francisco (US), University of Utah (US), Massachusetts General Hospital (US), Children's Center (US), Université de Montréal (CA), Stanford University (US)
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
Good health and well-being
Openalex Percentile: Top 29%
Peroxisome Proliferator-Activated Receptors
0.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.